New Patent Paves the Way for the Next Generation of Personalized Surgical Planning

The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent 12,239,384, further expanding its intellectual property portfolio around the Newton® soft tissue balancing technology.

Share this article
Newton Knee soft tissue balancing technology with GPS system

A newly granted patent originates from a series of dedicated applications that enable the software-driven evolution of the Newton technology, marking a significant advancement toward autonomous, personalized surgical planning.

Convertible Technology

The new patent builds upon previously awarded patents by leveraging a multitude of technologies to develop, execute and assess a patient-specific surgical protocol. While the patent uses a knee-centric workflow, the intellectual property applies to all joints, making the technology adaptable across various partial or total joint replacement.

Individualized Planning

“Newton empowers surgeons by seamlessly integrating anatomical landmarks, dynamic joint alignment and laxity acquisitions, and real-time adjustments. This advanced technology is poised to make a significant impact by expanding its abilities to deliver personalized, patient-specific planning across all joints,” said Laurent Angibaud, Senior Vice President of Advanced Surgical Technologies Development.

This achievement strengthens the Company’s impressive portfolio of nearly 50 patents dedicated to advancing soft tissue management. Powered by Active Intelligence®, the Newton Knee technique integrates with the GPS system to deliver dynamic soft tissue analytics, pre-resection insights and full-range personalized planning for balanced total joint replacement surgery.

More than a Planner

“Incorporating soft-tissue data as an intrinsic input greatly streamlines the set-up of surgical planning, potentially decreasing cognitive burden,” said James Huddleston, MD, of Stanford University. Dr. Huddleston states that these pending patent applications will:

  • Disclose machine learning-based methods for classifying patients
  • Further leverage joint laxities
  • Enables the potential for issuing personalized planning recommendations tailored to each patient.

Press & Media Contacts

Courtney Adkins
Marketing Communications Director
courtney.adkins@advita.com

Nancy Walsh
VP, Corporate & Marketing Communications
nancy.walsh@advita.com

Discover more

Sign up to receive email alerts with
the latest news, stories and updates.


Sign up to receive email alerts with the latest news, stories and updates.